• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EKOS CORPORATION EKOSONIC ENDOVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EKOS CORPORATION EKOSONIC ENDOVASCULAR CATHETER Back to Search Results
Model Number UNKNOWN
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Bradycardia (1751); Hemorrhage/Bleeding (1888); Low Blood Pressure/ Hypotension (1914)
Event Date 03/08/2017
Event Type  Injury  
Manufacturer Narrative
The subject experienced pulseless electrical activity during the apt procedure on (b)(6) 2017.Patient became bradycardic and hypotensive.Acls was initiated and the patient was placed on extracorporeal membrane oxygenation ecmo.The patient recovered from pea.There were no device malfunctions reported.The principle investigator classified the relationship of the event of pea as definitely related to the procedure.Relationship to ekos for all events is marked unknown.No additional information will be available.
 
Event Description
On 11 july 2019, a clinical study sae was reported.Subject (b)(6) is a retrospective patient enrolled in (b)(6).This patient is a (b)(6)-year-old female.The patient had ekos therapy initiated at 16:43 on (b)(6) 2017.She went into pulseless electrical activity (pea) and hypotension at 17:23.Acls was initiated and the patient was placed on ecmo.The event of pea is recorded as resolved by 17:40.On (b)(6) 2017, the patient had some blood in the et tube, graded as mild.It was noted that the blood in et tube occurred after apt treatment was completed and possibly due to from shock to the liver.The patient was extubated on (b)(6) 2017.On (b)(6) 2017, the patient experienced dyspnea and desaturated to 89% on 15l o2.The patient was placed on cpap with immediate relief.The patient was titrated off cpap and was on 14l o2.On (b)(6) 2017, the patient was reintubated.On (b)(6) 2017, the patient's ejection fraction was 35% when it was previously normal.An ivc filter was placed due to heart strain and lle clot burden.The principle investigator classified the relationship of the pea event as definitely related to the procedure.The principle investigator's assessment of the relationship to ekos for all events is marked as unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EKOSONIC ENDOVASCULAR CATHETER
Type of Device
EKOSONIC ENDOVASCULAR CATHETER
Manufacturer (Section D)
EKOS CORPORATION
11911 north creek parkway s
bothell WA 98011 8809
Manufacturer (Section G)
EKOS CORPORATION
11911 north creek parkway
bothell WA 98011 8809
Manufacturer Contact
sandara bausback-aballo
300 conshohocken state rd,
300 four falls corporate ctr.
west conshohocken, PA 19428-2998
6103311537
MDR Report Key8874650
MDR Text Key153999882
Report Number3001627457-2019-00022
Device Sequence Number1
Product Code KRA
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K140151
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type study
Reporter Occupation Physician
Type of Report Initial
Report Date 07/11/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/08/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/11/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age71 YR
-
-